Results 101 to 110 of about 11,699 (159)
ABSTRACT Aim Chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections remain major causes of liver‐related morbidity and mortality worldwide. Although Japan has implemented nationwide screening and treatment programs for decades, updated nationwide estimates and long‐term projections are limited.
Junko Tanaka +4 more
wiley +1 more source
Efficacy and safety of pyrimidine nucleos(t)ide therapy in thymidine kinase 2 deficiency. [PDF]
Hirano M +9 more
europepmc +1 more source
ABSTRACT Aim We evaluated how native vegetation cover influences the diversity of arachnid assemblages across multiple spatial scales in major Brazilian ecosystems. Location Brazil (Amazon and Atlantic rainforests, Cerrado savanna and Caatinga dry forest). Taxon Arachnida (Opiliones, Pseudoscorpiones and Scorpiones). Methods We sampled arachnids at 120
André F. A. Lira +26 more
wiley +1 more source
Outcomes of Nucleos(t)ide Analogue Discontinuation in Noncirrhotic Patients With Chronic Hepatitis B: A Retrospective Study. [PDF]
Bhatt S +8 more
europepmc +1 more source
The Silent Burden of Hepatitis B‐Related Stigma
ABSTRACT Individuals experiencing stigma related to chronic hepatitis B virus (HBV) infection often experience negative self‐beliefs, isolation, discrimination, and reduced willingness to engage with healthcare professionals. We aimed to understand the patient perspective of HBV‐related stigma and to summarize the patient experience of stigma in a ...
Verity Smith +6 more
wiley +1 more source
Monocyte-derived IL-1β predicts and promotes HBsAg decline in chronic hepatitis B patients under nucleoside analogue therapy. [PDF]
Shigeno S +15 more
europepmc +1 more source
ABSTRACT Hepatitis delta virus (HDV) infection causes chronic hepatitis D (CHD), the most severe form of chronic viral hepatitis with a high risk of progression to advanced liver disease. Off‐label pegylated interferon alpha was the primary treatment option in Europe prior to the introduction of bulevirtide, a first‐in‐class HDV entry inhibitor.
Monica Radu +11 more
wiley +1 more source
Emerging Immune‐Based Therapeutic Strategies in Hepatocellular Carcinoma
ABSTRACT Hepatocellular carcinoma (HCC) remains a leading cause of cancer‐related mortality worldwide despite recent advances in systemic therapy. The introduction of immune checkpoint inhibitors has substantially expanded treatment options for advanced disease; however, durable responses are observed only in a subset of patients.
Janine Kah +2 more
wiley +1 more source
ABSTRACT Background and Aims Chronic hepatitis B virus (HBV) infection is endemic in Uzbekistan. Previous data showed a high prevalence of anti‐hepatitis D virus (HDV) antibodies in HBsAg‐positive individuals. Limited data are available on disease severity, treatment availability and hepatocellular carcinoma (HCC) prevalence in patients with chronic ...
Malika E. Khodjaeva +12 more
wiley +1 more source
ABSTRACT Background & Aims We compared multibipolar radiofrequency ablation (mbpRFA) with open liver resection (OLR) or laparoscopic liver resection (LLR) in patients with HCCs within Milan. Methods This multicenter cohort study included patients treated by mbpRFA, OLR or LLR for HCC within the Milan Criteria, developed on advanced fibrosis in nine ...
Christian Hobeika +25 more
wiley +1 more source

